Keir Lewis

Keir Lewis i

Swansea University - Swansea / United Kingdom
Others
AD Scientific Index ID: 1352278
person_outline Keir Lewis's MOST POPULAR ARTICLES
1-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 397 (10285), 1637-1645, 202112532021
2-) Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trialPB Murphy, S Rehal, G Arbane, S Bourke, PMA Calverley, AM Crook, ...Jama 317 (21), 2177-2186, 20175212017
3-) Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort studyRA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...The Lancet Respiratory Medicine 9 (11), 1275-1287, 20214572021
4-) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...Medrxiv, 2021.06. 15.21258542, 2021468*2021
5-) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational studyRA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...The Lancet Respiratory Medicine 10 (8), 761-775, 20223512022